You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 24, December 27, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Video
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Patent Foramen Ovale and High-Altitude Pulmonary Edema

Yves Allemann, MD; Damian Hutter, MD; Ernst Lipp, MD; Claudio Sartori, MD; Hervé Duplain, MD; Marc Egli, MD; Stéphane Cook, MD; Urs Scherrer, MD; Christian Seiler, MD

JAMA. 2006;296:2954-2958.

Context  Individuals susceptible to high-altitude pulmonary edema (HAPE) are characterized by exaggerated pulmonary hypertension and arterial hypoxemia at high altitude, but the underlying mechanism is incompletely understood. Anecdotal evidence suggests that shunting across a patent foramen ovale (PFO) may exacerbate hypoxemia in HAPE.

Objective  We hypothesized that PFO is more frequent in HAPE-susceptible individuals and may contribute to more severe arterial hypoxemia at high altitude.

Design, Setting, and Participants  Case-control study of 16 HAPE-susceptible participants and 19 mountaineers resistant to this condition (repeated climbing to peaks above 4000 m and no symptoms of HAPE).

Main Outcome Measures  Presence of PFO determined by transesophageal echocardiography, estimated pulmonary artery pressure by Doppler echocardiography, and arterial oxygen saturation measured by pulse oximetry in HAPE-susceptible and HAPE-resistant participants at low (550 m) and high altitude (4559 m).

Results  The frequency of PFO was more than 4 times higher in HAPE-susceptible than in HAPE-resistant participants, both at low altitude (56% vs 11%, P = .004; odds ratio [OR], 10.9 [95% confidence interval {CI}, 1.9-64.0]) and high altitude (69% vs 16%, P = .001; OR, 11.7 [95% CI, 2.3-59.5]). At high altitude, mean (SD) arterial oxygen saturation prior to the onset of pulmonary edema was significantly lower in HAPE-susceptible participants than in the control group (73% [10%] vs 83% [7%], P = .001). Moreover, in the HAPE-susceptible group, participants with a large PFO had more severe arterial hypoxemia (65% [6%] vs 77% [8%], P = .02) than those with smaller or no PFO.

Conclusions  Patent foramen ovale was roughly 4 times more frequent in HAPE-susceptible mountaineers than in participants resistant to this condition. At high altitude, HAPE-susceptible participants with a large PFO had more severe hypoxemia. We speculate that at high altitude, a large PFO may contribute to exaggerated arterial hypoxemia and facilitate HAPE.


Author Affiliations: Department of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland (Drs Allemann, Hutter, Lipp, and Seiler); and Department of Internal Medicine and Botnar Center for Extreme Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (Drs Sartori, Duplain, Egli, Cook, and Scherrer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

High-Altitude Pulmonary Edema and Patent Foramen Ovale
Peter J. Fagenholz and N. Stuart Harris
JAMA. 2007;297(13):1432.
EXTRACT | FULL TEXT  

High-Altitude Pulmonary Edema and Patent Foramen Ovale
Christoph Dehnert, Peter Bärtsch, Ekkehard Grünig, and Derliz Mereles
JAMA. 2007;297(13):1432.
EXTRACT | FULL TEXT  

High-Altitude Pulmonary Edema and Patent Foramen Ovale—Reply
Yves Allemann, Christian Seiler, Urs Scherrer, and Claudio Sartori
JAMA. 2007;297(13):1432-1433.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Atrial Septal Defects
John L. Zeller, Cassio Lynm, and Richard M. Glass
JAMA. 2006;296(24):3036.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Update in the Understanding of Respiratory Limitations to Exercise Performance in Fit, Active Adults
Dempsey et al.
Chest 2008;134:613-622.
ABSTRACT | FULL TEXT  

Illnesses at High Altitude
Schoene
Chest 2008;134:402-416.
ABSTRACT | FULL TEXT  

Patent Foramen Ovale Closure Without Echocardiographic Control: Use of "Standby" Intracardiac Ultrasound
Hildick-Smith et al.
J Am Coll Cardiol Intv 2008;1:387-391.
ABSTRACT | FULL TEXT  

Pathophysiology of Congenital Heart Disease in the Adult: Part I: Shunt Lesions
Sommer et al.
Circulation 2008;117:1090-1099.
FULL TEXT  

Effect of Altitude on the Heart and the Lungs
Bartsch and Gibbs
Circulation 2007;116:2191-2202.
FULL TEXT  

High-Altitude Pulmonary Edema and Patent Foramen Ovale
Fagenholz and Harris
JAMA 2007;297:1432-1432.
FULL TEXT  

High-Altitude Pulmonary Edema and Patent Foramen Ovale
Dehnert et al.
JAMA 2007;297:1432-1432.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.